+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

From
From
From
From
From
From
Insulin Delivery Systems - Global Strategic Business Report - Product Thumbnail Image

Insulin Delivery Systems - Global Strategic Business Report

  • Report
  • January 2026
  • 272 Pages
  • Global
From
Insulin Pen Needles - Global Strategic Business Report - Product Thumbnail Image

Insulin Pen Needles - Global Strategic Business Report

  • Report
  • January 2026
  • 193 Pages
  • Global
From
Smart Insulin Pens and Pumps - Global Strategic Business Report - Product Thumbnail Image

Smart Insulin Pens and Pumps - Global Strategic Business Report

  • Report
  • January 2026
  • 131 Pages
  • Global
From
Insulin Pens - Global Strategic Business Report - Product Thumbnail Image

Insulin Pens - Global Strategic Business Report

  • Report
  • January 2026
  • 276 Pages
  • Global
From
Insulin Pumps - Global Strategic Business Report - Product Thumbnail Image

Insulin Pumps - Global Strategic Business Report

  • Report
  • January 2026
  • 258 Pages
  • Global
From
From
Human Insulin Market 2025-2033 - Product Thumbnail Image

Human Insulin Market 2025-2033

  • Report
  • March 2025
  • 145 Pages
  • Global
From
From
Polycystic Ovary Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Ovary Syndrome- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Type 1 Diabetes Market Report and Forecast 2025-2034 - Product Thumbnail Image

Type 1 Diabetes Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
Congenital Hyperinsulinism (CHI) Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Congenital Hyperinsulinism (CHI) Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
Type 2 Diabetes Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Type 2 Diabetes Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more